Manufacture

Engineered E. coli colonies could be trump cards in the war against drug resistance.

The first US biosimilar - Zarxio from Sandoz - has been cleared for market. But the judges say it wasn't an easy decision.

After 28 years of R&D at GSK, the world has its first malaria vaccine.

A new mathematical model aims to improve drugs for cancer, viruses and bacteria.

The stability of a protein sample and its tendency to aggregate is explored using a combination of SEC-MALS and DLS

Taylor Dispersion measurements are used to monitor self-association and oligomeric state in a variety of buffer conditions.

Quality by Design: we’ve all heard the phrase – and know we should be fully on board with the philosophy. But how?

Complex amines from common chemicals - it's not magic, just clever chemistry.

Could existing drugs be repurposed as a shortcut to treating Ebola?

Manufacturers must prove that new drug products are free of cancer-causing impurities